CDK10 loss primes tumor cells for transcriptional vulnerability and sensitizes to CDK12/13 inhibition.
Saved in:
| Title: | CDK10 loss primes tumor cells for transcriptional vulnerability and sensitizes to CDK12/13 inhibition. |
|---|---|
| Authors: | Islam S; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.; Graduate School of Medicine, Kyoto University, Kyoto, Japan., Tarumoto Y; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan., Takano M; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan., Sugino S; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan., Nishibuchi G; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan., Mizutani A; Chordia Therapeutics, Inc, Kanagawa, Japan., Yamakawa H; Chordia Therapeutics, Inc, Kanagawa, Japan., Morishita D; Chordia Therapeutics, Inc, Kanagawa, Japan., Yusa K; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan. k.yusa@infront.kyoto-u.ac.jp. |
| Source: | Cell death & disease [Cell Death Dis] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
